Pharma analyst at Macquarie Research, Abhishek Singhal, spoke to CNBC-TV18 about the key takeaways from the management meet post Ranbaxy’s settlement with the US FDA.
first published: Dec 22, 2011 12:25 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty sees best single day rally since June 2025, nears record high | Closing Bell

Live: Can Nifty claim new lifetime highs in December series? | Opening Bell

Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell

Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell
You are already a Moneycontrol Pro user.

